Track topics on Twitter Track topics that are important to you
PharmAbcine CEO Jin-San Yoo talks to Scrip about the company’s overseas clinical trial strategy, pipeline assets, and ambitions for lead...
There were only two biopharma IPOs in the US during August, bringing the year's total to 47. But with eight...
Reata reaps benefit from 2009 licensing deal with Kyowa Hakko Kirin for bardoxolone as transcription factor activator moves into pivotal...
PharmAbcine, Inc, a clinical-stage biotech company developing novel antibody therapeutics for multiple cancer indications announces that the company received “Study May P...
SummaryPharmAbcine Inc PharmAbcine is a biotechnology company that discovers and develops human therapeutic monoclonal antibodies. The company offers lead MAB and bispecific MAB products. It provides ...
PharmAbcine is a leading clinical stage biologics company that develops fully human therapeutic antibody (mAb) and next generation multispecific antibody therapeutics based on in-...
PharmAbcine is a specialized biotech company that develops fully human therapeutic monoclonal antibody (mAb) using innovative discovery technology and excellent human resources for the treatment of hu...
We have published hundreds of PharmAbcine Inc. news stories on BioPortfolio along with dozens of PharmAbcine Inc. Clinical Trials and PubMed Articles about PharmAbcine Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PharmAbcine Inc. Companies in our database. You can also find out about relevant PharmAbcine Inc. Drugs and Medications on this site too.